Vigil Market Cap from 2010 to 2024

VIGL Stock  USD 2.47  0.17  7.39%   
Vigil Neuroscience Market Cap yearly trend continues to be quite stable with very little volatility. Market Cap may rise above about 248.6 M this year. From the period between 2010 and 2024, Vigil Neuroscience, Market Cap regression line of its data series had standard deviation of  104,265,258 and standard deviation of  104,265,258. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
130.8 M
Current Value
248.6 M
Quarterly Volatility
104.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vigil Neuroscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vigil Neuroscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 379.1 K, Interest Expense of 85.2 K or Selling General Administrative of 17.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.18. Vigil financial statements analysis is a perfect complement when working with Vigil Neuroscience Valuation or Volatility modules.
  
Check out the analysis of Vigil Neuroscience Correlation against competitors.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.

Latest Vigil Neuroscience's Market Cap Growth Pattern

Below is the plot of the Market Cap of Vigil Neuroscience over the last few years. It is Vigil Neuroscience's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vigil Neuroscience's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Vigil Market Cap Regression Statistics

Arithmetic Mean315,184,655
Geometric Mean270,552,256
Coefficient Of Variation33.08
Mean Deviation72,903,820
Median357,539,132
Standard Deviation104,265,258
Sample Variance10871.2T
Range376.7M
R-Value(0.50)
Mean Square Error8746.3T
R-Squared0.25
Significance0.06
Slope(11,725,315)
Total Sum of Squares152197.4T

Vigil Market Cap History

2024248.6 M
2023130.8 M
2022396.1 M
202119.4 M

About Vigil Neuroscience Financial Statements

Vigil Neuroscience investors utilize fundamental indicators, such as Market Cap, to predict how Vigil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Market Cap130.8 M248.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports:
Check out the analysis of Vigil Neuroscience Correlation against competitors.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Return On Assets
(0.40)
Return On Equity
(0.70)
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.